For Publishers
DiscoveryMetadataPeer reviewHostingPublishing
For Researchers
JoinPublishReviewCollect
Register
Blog
About
Search
Advanced search
My ScienceOpen
Search
For Publishers
For Researchers
Blog
About
9
views
0
references
 Top references
cited by
12
    
0 reviews
 Review
0
comments
 Comment
0
recommends
+1 Recommend
0 collections
    0
    shares
      0
      similar
       All similar
      • Record: found
      • Abstract: found
      • Article: not found

      Mechanism of Glucagon-Like Peptide 1 Improvements in Type 2 Diabetes Mellitus and Obesity.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          The purpose of this review is to emphasize the pivotal role of glucagon-like peptide 1 (GLP-1) in tackling the parallel epidemics of obesity and type 2 diabetes (T2DM).

          Related collections

          Author and article information

          Journal
          Journal ID (iso-abbrev): Curr Obes Rep
          Title: Current obesity reports
          Publisher: Springer Science and Business Media LLC
          ISSN (Electronic): 2162-4968
          ISSN (Print): 2162-4968
          Publication date (Electronic): Sep 2019
          Volume: 8
          Issue: 3
          Affiliations
          [1 ] Section of Endocrinology, Diabetes, Nutrition, and Weight Management, Boston University School of Medicine and Boston Medical Center, 720 Harrison Avenue, Doctor's Office Building, Suite 8100, Boston, MA, 02118, USA. Eric.Nolen-Doerr@bmc.org.
          [2 ] Section of Endocrinology, Diabetes, Nutrition, and Weight Management, Boston University School of Medicine and Boston Medical Center, 720 Harrison Avenue, Doctor's Office Building, Suite 8100, Boston, MA, 02118, USA. Mary-Catherine.Stockman@bmc.org.
          [3 ] Section of Endocrinology, Diabetes, Nutrition, and Weight Management, Boston University School of Medicine and Boston Medical Center, 720 Harrison Avenue, Doctor's Office Building, Suite 8100, Boston, MA, 02118, USA. Ivania.Rizo@bmc.org.
          Article
          Publisher Item ID: 10.1007/s13679-019-00350-4
          DOI: 10.1007/s13679-019-00350-4
          PubMed ID: 31124035
          SO-VID: d693fb2c-1667-4ce0-af96-36fd3caf449a
          History

          Keywords: Incretin,Cardiovascular disease,Obesity,Weight loss,Type 2 diabetes,Glucagon-like peptide-1
          Data availability:
          Keywords: Incretin, Cardiovascular disease, Obesity, Weight loss, Type 2 diabetes, Glucagon-like peptide-1

          Comments

          Comment on this article